Drug Type Universal CAR-T |
Synonyms CAR 19 iNKT, ALA101 |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Immunologic cytotoxicity, Natural killer cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | AU | 17 Mar 2023 | |
Solid tumor | Preclinical | AU | 17 Mar 2023 | |
Lymphoma | Preclinical | AU | 20 Apr 2022 |